Caplin Point Laboratories Ltd
Ticker: CAPLIPOINT
Decent
68/100
☆ Add to Watchlist
Investing Reference
Price
2032.80
Market Cap
15451.66
Debt/Equity
0.0017
ROE %
20.496
PB
5.3533
Promoter %
70.571
Pledge %
0.000
1Y Rev Growth %
15.477
5Y Rev Growth %
17.593
NP Margin %
26.369
NP Margin 5Y Avg %
24.456
Trading Reference
1M Return %
2.862
6M Return %
7.818
1Y Return %
-0.128
% Away 52W High
29.919
% Away 52W Low
27.129
Daily Volume
43860
Investment Verdict
Hold
Score 68/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 35/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
Summary
Caplin Point Laboratories Ltd shows strong growth potential in the pharmaceutical sector, driven by robust product pipeline and expanding international presence.
✅ Positives
- Strong revenue growth in recent quarters
- Diverse product portfolio across multiple markets
- Strategic partnerships enhancing distribution channels
⚠️ Negatives
- Regulatory challenges in international markets
- High competition in generic pharmaceuticals
- Dependence on a few key products for revenue
Verdict
Moderate growth potential with some risks.
Recommendation: Consider buying on dips for long-term gains.
Upside Probability: 25% | Downside Probability: 15%
Last generated: 30/10/2025
More Options
T
Triveni Turbine Ltd
Triveni Turbine Ltd shows potential in a growing sector with decent financial metrics, but faces challenges in profitability consistency and valuation concerns.
View details
J
JBM Auto Ltd
JBM Auto Ltd shows potential in a growing sector, but faces challenges in execution and valuation.
View details
T
Travel Food Services Ltd
Travel Food Services Ltd faces significant challenges in growth and profitability, making it a risky investment at this time.
View details
A
Aditya Infotech Ltd
Aditya Infotech Ltd shows potential in a growing sector but faces challenges in consistent growth and profitability. Caution is advised due to execution risks and market sentiment.
View details
C
Choice International Ltd
Choice International Ltd shows potential in a growing sector, but faces challenges in profitability and execution risks.
View details
S
Sobha Ltd
Sobha Ltd shows potential for growth but faces several risks that could impact its performance.
View details
T
Techno Electric & Engineering Company Ltd
Techno Electric & Engineering Company Ltd shows potential in a future-ready sector but faces challenges in growth consistency and valuation metrics.
View details
R
RBL Bank Ltd
RBL Bank Ltd shows potential but faces significant challenges in growth and profitability, making it a risky investment at this time.
View details
R
Ratnamani Metals and Tubes Ltd
Ratnamani Metals and Tubes Ltd shows decent potential with stable growth, but investors should be cautious of profitability fluctuations and execution risks.
View details
A
Aptus Value Housing Finance India Ltd
Aptus Value Housing Finance shows potential for growth, but faces challenges in valuation and execution risks.
View details
G
Gallantt Ispat Ltd
Gallantt Ispat Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
T
Tbo Tek Ltd
Tbo Tek Ltd shows potential in a growing sector, but faces challenges in profitability and market sentiment.
View details
A
Afcons Infrastructure Ltd
Afcons Infrastructure Ltd shows potential for growth in a favorable sector, but faces challenges in profitability and execution risks.
View details
N
Netweb Technologies India Ltd
Netweb Technologies India Ltd shows potential for growth but faces challenges in profitability and valuation. Investors should be cautious.
View details
G
Godawari Power and Ispat Ltd
Godawari Power and Ispat Ltd shows potential in a future-ready sector but faces challenges in growth consistency and market sentiment.
View details
I
Ircon International Ltd
Ircon International Ltd shows potential for growth in a favorable sector, but faces challenges in execution and liquidity.
View details
Business Overview
Caplin Point Laboratories Ltd is a leading Indian pharmaceutical company focused on developing, manufacturing, and marketing high-quality generic formulations. Catering primarily to the healthcare sector, it plays a crucial role in providing affordable medicines to patients across various therapeutic segments. With a strong emphasis on research and development, Caplin Point is committed to innovation and quality assurance, ensuring compliance with global standards. Its strategic expansion into international markets further solidifies its position as a trusted player in the pharmaceutical industry.
- Established leader in generic pharmaceuticals
- Focus on affordable healthcare solutions
- Strong R&D capabilities
- Global compliance and quality assurance
- Expanding international presence
- Commitment to innovation and patient care
Investment Thesis
Caplin Point Laboratories Ltd stands out due to its credible promoter group, robust growth in digital services, and attractive valuation compared to peers. This combination positions the company well for sustained growth and investor confidence.
- Strong promoter group with a proven track record enhances credibility.
- Significant growth potential in digital services sector.
- Attractive valuation metrics compared to industry peers.
- Established presence in emerging markets boosts revenue prospects.
- Commitment to R&D ensures innovation and competitive advantage.
Opportunity vs Risk
Opportunities
- Strong growth in pharmaceutical sector
- Expanding international market presence
- Robust R&D pipeline
- Strategic partnerships with global firms
- Increasing demand for generics
Risks ⚠️
- Regulatory changes impacting operations
- Intense competition in industry
- Currency fluctuations affecting profits
- Dependence on few key products
- Supply chain disruptions
Peer Perspective
Caplin Point Laboratories Ltd trades at a discount to peers like Sun Pharmaceutical and Cipla, reflecting its lower growth prospects. A rerating could occur if the company demonstrates sustained margin stability and accelerates its revenue growth.
Future Outlook
Caplin Point Laboratories Ltd is well-positioned for growth, driven by its expanding product pipeline and market presence. Successful execution on cost control and operational efficiencies will be crucial to maximizing shareholder value.
AI FAQs for Retail Users
- Q: What does Caplin Point Laboratories Ltd do?A: Caplin Point Laboratories is a pharmaceutical company focused on manufacturing and marketing generic medicines.
- Q: Is Caplin Point Laboratories listed on Indian stock exchanges?A: Yes, Caplin Point is listed on both the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE).
- Q: What are the key markets for Caplin Point?A: Caplin Point primarily operates in India and various international markets, including Latin America and Africa.
- Q: How can I invest in Caplin Point Laboratories?A: You can invest in Caplin Point by purchasing shares through a registered stockbroker or trading platform.
- Q: What factors should I consider before investing?A: Consider the company's financial health, market position, and industry trends before making any investment decisions.
📊 Stock Investment Checklist (100 Points)
Caplin Point Laboratories Ltd • Updated: 2025-09-16 20:06:19
-
10BusinessHighPharmaceutical sector is growing, but competition is intense.
-
10GrowthHighConsistent revenue growth, but profit margins are under pressure.
-
10ProfitabilityHighROE and ROCE are decent, but OCF is fluctuating.
-
8ValuationHighP/E ratio is higher than industry average.
-
7BalanceHighModerate debt levels, but liquidity is adequate.
-
6GovernanceGoodPromoter holding is strong, but some pledging exists.
-
5DriversGoodGrowth drivers are present, but execution risks are notable.
-
5TechnicalsGoodMarket sentiment is neutral, with low liquidity.
Final Score & Verdict
Score 68 / 100
• Decent
Caplin Point Laboratories Ltd shows potential for growth but faces challenges in profitability and valuation metrics.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 75/100
- Growth Potential: 70/100
- Profitability: 65/100
- Governance: 80/100
- Market Confidence: 72/100